Tubulis
Cambridge, United States· Est.
Tubulis develops antibody-drug conjugates (ADCs) for cancer by creating highly stable and selective therapeutics.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $489M
About
Tubulis develops antibody-drug conjugates (ADCs) for cancer by creating highly stable and selective therapeutics.
OncologyAntibodies
Funding History
2Total raised:$489M
Venture$361M
Series B$128M